Salmena L - Search Results

1

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, Ghadirian P, Neuhausen SL, Demsky R, Tung N, Ainsworth P, Senter L, Eisen A, Eng C, Singer C, Ginsburg O, Blum J, Huzarski T, Poll A, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Kotsopoulos J, et al. Among authors: salmena l. Breast Cancer Res. 2012 Mar 9;14(2):R42. doi: 10.1186/bcr3138. Breast Cancer Res. 2012. PMID: 22405187 Free PMC article.

2

BRCA1 and BRCA2 mutations and breast cancer.

Narod SA, Salmena L. Narod SA, et al. Among authors: salmena l. Discov Med. 2011 Nov;12(66):445-53. Discov Med. 2011. PMID: 22127115 Free article.

3

BRCA1 haploinsufficiency: consequences for breast cancer.

Salmena L, Narod S. Salmena L, et al. Womens Health (Lond). 2012 Mar;8(2):127-9. doi: 10.2217/whe.12.2. Womens Health (Lond). 2012. PMID: 22375716 Free article.

4

BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane.

Kotsopoulos J, Zhang S, Akbari M, Salmena L, Llacuachaqui M, Zeligs M, Sun P, Narod SA. Kotsopoulos J, et al. Among authors: salmena l. Br J Cancer. 2014 Sep 23;111(7):1269-74. doi: 10.1038/bjc.2014.391. Epub 2014 Jul 15. Br J Cancer. 2014. PMID: 25025957 Free PMC article. Clinical Trial.

5

Uninterrupted Sedentary Behavior Downregulates BRCA1 Gene Expression.

Pettapiece-Phillips R, Kotlyar M, Chehade R, Salmena L, Narod SA, Akbari M, Jurisica I, Kotsopoulos J. Pettapiece-Phillips R, et al. Among authors: salmena l. Cancer Prev Res (Phila). 2016 Jan;9(1):83-8. doi: 10.1158/1940-6207.CAPR-15-0291. Epub 2015 Nov 2. Cancer Prev Res (Phila). 2016. PMID: 26526989

6

Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific.

Chehade R, Pettapiece-Phillips R, Salmena L, Kotlyar M, Jurisica I, Narod SA, Akbari MR, Kotsopoulos J. Chehade R, et al. Among authors: salmena l. Breast Cancer Res. 2016 Aug 17;18(1):87. doi: 10.1186/s13058-016-0739-8. Breast Cancer Res. 2016. PMID: 27534398 Free PMC article.

7

Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Odén L, Akbari M, Zaman T, Singer CF, Sun P, Narod SA, Salmena L, Kotsopoulos J. Odén L, et al. Among authors: salmena l. Oncotarget. 2016 Dec 27;7(52):86687-86694. doi: 10.18632/oncotarget.13417. Oncotarget. 2016. PMID: 27893411 Free PMC article.

8

Serum osteoprotegerin levels and mammographic density among high-risk women.

Moran O, Zaman T, Eisen A, Demsky R, Blackmore K, Knight JA, Elser C, Ginsburg O, Zbuk K, Yaffe M, Narod SA, Salmena L, Kotsopoulos J. Moran O, et al. Among authors: salmena l. Cancer Causes Control. 2018 Jun;29(6):507-517. doi: 10.1007/s10552-018-1035-y. Epub 2018 Apr 20. Cancer Causes Control. 2018. PMID: 29679262

9

Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Zaman T, Sun P, Narod SA, Salmena L, Kotsopoulos J. Zaman T, et al. Among authors: salmena l. Oncotarget. 2019 Mar 29;10(25):2475-2483. doi: 10.18632/oncotarget.26810. eCollection 2019 Mar 29. Oncotarget. 2019. PMID: 31069010 Free PMC article.

10

Correlates of Circulating Osteoprotegerin in Women with a Pathogenic or Likely Pathogenic Variant in the BRCA1 Gene.

Park SS, Zaman T, Kim SJ, Brooks JD, Wong AKO, Lubiński J, Narod SA, Salmena L, Kotsopoulos J. Park SS, et al. Among authors: salmena l. Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):298-305. doi: 10.1158/1055-9965.EPI-23-0577. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38015775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters